The Department aims to understand the complex mechanisms of infectious and inflammatory disease processes in order to enable new ways to diagnose, prevent or cure human diseases. Such a strategy requires the existence of a highly interdisciplinary research environment with intensive collaboration of basic and clinical immunologists, engineers, biochemists, computational and systems biologists, public health specialists and clinician scientists.
The Department of Infection and Immunity (DII) defines itself as a clinical-translational research center at the crossroads of basic discovery, clinical application, and public health service.
As such, the major focus of DII is on the analysis of complex mechanisms of infectious and inflammatory disease processes. With a multi-disciplinary approach, the research strategy is based on the following elements: experimental discovery, bridging to clinical application and technology development. Major unsolved medical questions in the areas of inflammation (allergy, asthma, autoimmunity), cancer and infectious diseases (HIV) drive DII’s current and future research agenda. The long-term objective of the DII is to develop into a center of complex immune system analysis in order to provide a better understanding of immune-mediated disease pathologies and infectious diseases.
Director of department
The establishment of the Department of Infection and Immunity was concluded in September 2014 with the appointment of Markus Ollert as its inaugural director.
Prof Markus Ollert has long-term expertise in the field of Allergy and Dermatology. Markus Ollert was appointed full professor and faculty member at Odense University Hospital of the University of Southern Denmark in January 2015.